APA (7th ed.) Citation

Dent, P., Booth, L., Poklepovic, A., & Hancock, J. F. Neratinib as a Potential Therapeutic for Mutant RAS and Osimertinib-Resistant Tumours. European Medical Journal.

Chicago Style (17th ed.) Citation

Dent, Paul, Laurence Booth, Andrew Poklepovic, and John F. Hancock. Neratinib as a Potential Therapeutic for Mutant RAS and Osimertinib-Resistant Tumours. European Medical Journal.

MLA (9th ed.) Citation

Dent, Paul, et al. Neratinib as a Potential Therapeutic for Mutant RAS and Osimertinib-Resistant Tumours. European Medical Journal.